seed
Stage
1
Investors
About
Dilafor develops pharmaceutical products to reduce risks associated with the initiation of labor in term pregnant women, based on a proprietary drug candidate, tafoxiparin, which improves cervical ripening and facilitates spontaneous labor onset.
Explore Dilafor's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.